Nozawa S - Search Results

1

[The biological property of ovarian cancers is affected by endometriosis--with special reference to ovarian clear cell adenocarcinoma].

Aoki D, Komiyama S, Susumu N, Nozawa S. Aoki D, et al. Among authors: nozawa s. Nihon Rinsho. 2001 Jan;59 Suppl 1:213-6. Nihon Rinsho. 2001. PMID: 11235169 Review. Japanese. No abstract available.

2

Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation.

Komiyama S, Aoki D, Tominaga E, Susumu N, Udagawa Y, Nozawa S. Komiyama S, et al. Among authors: nozawa s. Gynecol Oncol. 1999 Mar;72(3):342-6. doi: 10.1006/gyno.1998.5284. Gynecol Oncol. 1999. PMID: 10053105

3

Subcellular localization of blood group Leb carbohydrate antigen (MSN-1-reactive antigen) in endometrial cancer cells.

Susumu N, Kawakami H, Aoki D, Hirano H, Nozawa S. Susumu N, et al. Among authors: nozawa s. Cancer Res. 1993 Aug 1;53(15):3643-8. Cancer Res. 1993. PMID: 8339270

4

[Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].

Nozawa S, Udagawa Y, Ito K, Susumu N, Sasaki H, Aoki D. Nozawa S, et al. Gan To Kagaku Ryoho. 1993 Feb;20(2):279-85. Gan To Kagaku Ryoho. 1993. PMID: 8434967 Japanese.

5

Carbohydrate epitopes and mucins expressed by 17 human ovarian carcinoma cell lines.

Tamada Y, Iida S, Aoki D, Nozawa S, Irimura T. Tamada Y, et al. Among authors: nozawa s. Oncol Res. 1999;11(5):233-41. Oncol Res. 1999. PMID: 10608618

6

Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers.

Suzuki T, Aoki D, Susumu N, Udagawa Y, Nozawa S. Suzuki T, et al. Among authors: nozawa s. Int J Oncol. 2000 Dec;17(6):1131-9. doi: 10.3892/ijo.17.6.1131. Int J Oncol. 2000. PMID: 11078798

7

[Hormonal therapy for endometrial adenocarcinoma].

Susumu N, Aoki D, Suzuki N, Nozawa S. Susumu N, et al. Among authors: nozawa s. Gan To Kagaku Ryoho. 2001 Jul;28(7):934-45. Gan To Kagaku Ryoho. 2001. PMID: 11478142 Review. Japanese.

8

Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin.

Komuro Y, Udagawa Y, Susumu N, Aoki D, Kubota T, Nozawa S. Komuro Y, et al. Among authors: nozawa s. Jpn J Cancer Res. 2001 Nov;92(11):1242-50. doi: 10.1111/j.1349-7006.2001.tb02146.x. Jpn J Cancer Res. 2001. PMID: 11714450 Free PMC article.

9

Efficient screening for ovarian cancers using a combination of tumor markers CA602 and CA546.

Saito M, Aoki D, Susumu N, Suzuki A, Suzuki N, Udagawa Y, Nozawa S. Saito M, et al. Among authors: nozawa s. Int J Gynecol Cancer. 2005 Jan-Feb;15(1):37-44. doi: 10.1111/j.1048-891X.2005.15004.x. Int J Gynecol Cancer. 2005. PMID: 15670295 Free article.

10

Chemosensitivity testing of ovarian cancer using the histoculture drug response assay: sensitivity to cisplatin and clinical response.

Nakada S, Aoki D, Ohie S, Horiuchi M, Suzuki N, Kanasugi M, Susumu N, Udagawa Y, Nozawa S. Nakada S, et al. Among authors: nozawa s. Int J Gynecol Cancer. 2005 May-Jun;15(3):445-52. doi: 10.1111/j.1525-1438.2005.15307.x. Int J Gynecol Cancer. 2005. PMID: 15882168 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

629 results

Search Page

Filters